After his presentation at ACR 2020, we spoke with Anthony Sebba (Arthritis Associates, FL, USA) about the importance of studying pain as a patient reported outcome in rheumatoid arthritis and what further studies are needed. The abstract ‘Pain and Other Patient-Reported Outcomes in Patients with Rheumatoid Arthritis Who Did or Did Not Achieve Treatment Response Based on Improvement in Swollen Joints in Tocilizumab Clinical Trials.’ (ABSTRACT NUMBER: 1237) was presented at the virtual ACR Convergence 2020, 5-9 November 2020.
Questions
- What are the clinical implications of the findings from this study? (0:08)
- What further studies are needed? (7:11)
Disclosures: Consultant or speaker for Genentech, Sanofi, Lilly, Gilead and Amgen.
Support: Interview and filming supported by Touch Medical Media.
Filmed in coverage of the ACR 2020 Annual Meeting (Virtual).
